UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 27, 2009
INVERNESS MEDICAL INNOVATIONS, INC.
(Exact name of registrant as specified in charter)
|
|
|
|
|
Delaware
|
|
1-16789
|
|
04-3565120 |
|
|
|
|
|
(State or Other Jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer |
of Incorporation)
|
|
|
|
Identification No.) |
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453
(Address of Principal Executive Offices) (Zip Code)
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02. Results of Operations And Financial Condition.
On April 27, 2009, Inverness Medical Innovations, Inc. (the Company) issued a press release
entitled Inverness Medical Innovations Announces First Quarter 2009 Results, a copy of which is
furnished with this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits.
|
|
|
Exhibit No. |
|
Description |
|
|
|
99.1
|
|
Press Release dated April 27, 2009, entitled Inverness
Medical Innovations Announces First Quarter 2009 Results |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
INVERNESS MEDICAL INNOVATIONS, INC.
|
|
Date: April 27, 2009 |
By: |
/s/ David Teitel
|
|
|
|
David Teitel |
|
|
|
Chief Financial Officer |
|
|
EXHIBIT INDEX
|
|
|
Exhibit No. |
|
Description |
|
|
|
99.1
|
|
Press Release dated April 27, 2009, entitled Inverness
Medical Innovations Announces First Quarter 2009 Results |